Transcatheter closure of secundum atrial septal defects

Suhaib Kazmouz1, Damien Kenny, Qi-Ling Cao

  • 1Rush Center for Congenital & Structural Heart Disease, Department of Medicine and Pediatrics, Rush University Medical Center, Chicago, Illinois 60612, USA.

Insights

Transcatheter closure is an evolving treatment for atrial septal defects (ASD), a common congenital heart issue. This review covers device evolution, outcomes, and complications, including device erosion concerns.

Area of Science:

  • Cardiology
  • Medical Devices
  • Congenital Heart Disease

Background:

  • Atrial septal defect (ASD) is a frequent congenital heart defect in children and adults.
  • It accounts for a significant portion of congenital heart disease (CHD) diagnoses.

Purpose of the Study:

  • To review the advancements in transcatheter closure for ASD.
  • To discuss current indications, follow-up protocols, and patient outcomes.
  • To highlight complications, particularly device erosion.

Main Methods:

  • Literature review of transcatheter ASD closure techniques and devices.
  • Analysis of clinical outcomes and complication data.
  • Focus on device-related issues, including erosion.

Main Results:

  • Transcatheter closure has evolved significantly as a treatment option for ASD.
  • Established indications, follow-up strategies, and outcomes are presented.
  • Device erosion remains a notable complication requiring attention.

Conclusions:

  • Transcatheter ASD closure is a well-established and evolving therapeutic approach.
  • Careful patient selection, device choice, and monitoring are crucial for optimal outcomes.
  • Ongoing research aims to minimize complications like device erosion.